Cargando…

Examining the direct and indirect effects of trust in motivating COVID-19 vaccine uptake

OBJECTIVES: This study aims to investigate how trust in healthcare providers, public health agencies, politicians, and pharmaceutical companies shaped people’s attitudes and behavioral intention associated with COVID-19 vaccination, directly and indirectly via the mediation of vaccine evaluation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Sixiao, Chu, Haoran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840822/
https://www.ncbi.nlm.nih.gov/pubmed/35181177
http://dx.doi.org/10.1016/j.pec.2022.02.009
Descripción
Sumario:OBJECTIVES: This study aims to investigate how trust in healthcare providers, public health agencies, politicians, and pharmaceutical companies shaped people’s attitudes and behavioral intention associated with COVID-19 vaccination, directly and indirectly via the mediation of vaccine evaluation and emotions. METHODS: A two-wave longitudinal survey (N = 534) was employed in late 2020 and early 2021 to assess the direct and indirect relationships between trust on people’s attitude toward the COVID-19 vaccine, vaccination intention, and actual vaccine uptake. RESULTS: Results show that trust was positively associated with attitude toward the COVID-19 vaccines and vaccination intention, both directly and indirectly via the mediation of vaccine evaluation, hope, and anger. Vaccination intention also mediated trust’s influence on vaccine uptake. CONCLUSION: Trust in health providers, vaccine manufacturers, and public health agencies are vital to public acceptance of the COVID-19 vaccine. PRACTICE IMPLICATIONS: Healthcare providers and vaccine manufacturers may serve as the most effective source to communicate COVID-19 vaccine-related information. Trusted health communicators need to highlight the effectiveness and safety of the vaccine while maintaining a positive tone.